Oncternal Therapeutics

Filed a patent for "glycoengineered forms of ror-1 modalities and methods of use" on Tue, August 1, 2023

Filed a patent for "glycoengineered forms of ror-1 modalities and methods of use" on Thu, December 7, 2023

Filed a patent for "combination therapies for the treatment of cancer" on Tue, December 20, 2022

Filed a patent for "combination treatment methods for cancer with tp53 mutation" on Mon, February 27, 2023

Filed a patent for "antibody formulations" on Tue, June 28, 2022

Filed a patent for "combinations of egfr inhibitors and ror1 inhibitors for the treatment of cancer" on Thu, March 9, 2023